$BFS
SAUL CENTERS, INC. Stock $bfs

$bfs Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000090725423000039 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$63.71M	$63.05M
YoY Change	5.67%	1.46%
Cost Of Revenue	$16.45M	$16.28M
YoY Change	11.17%	-3.99%
Gross Profit	$47.26M	$46.77M
YoY Change	3.88%	3.5%
Gross Profit Margin	74.18%	74.18%
Selling, General & Admin	$5.678M	$5.268M
YoY Change	0.23%	10.49%
% of Gross Profit	12.01%	11.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$12.11M	$12.02M
YoY Change	-2.12%	-2.51%
% of Gross Profit	25.63%	25.69%
Operating Expenses	$17.86M	$17.19M
YoY Change	-1.13%	0.4%
Operating Profit	$29.40M	$29.58M
YoY Change	7.17%	5.39%
Interest Expense	$12.36M	$11.93M
YoY Change	18.17%	12.52%
% of Operating Profit	42.04%	40.33%
Other Income/Expense, Net
YoY Change
Pretax Income	$17.19M	$17.66M
YoY Change	1.13%	0.98%
Income Tax
% Of Pretax Income
Net Earnings	$13.16M	$13.50M
YoY Change	1.12%	1.03%
Net Earnings / Revenue	20.66%	21.42%
Basic Earnings Per Share	$0.43	$0.45
Diluted Earnings Per Share	$0.43	$0.45
COMMON SHARES
Basic Shares Outstanding	23.93M shares	23.91M shares
Diluted Shares Outstanding	24.04M shares	24.03M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.47M	$11.81M
YoY Change	2.74%	-4.07%
Cash & Equivalents	$11.47M	$11.81M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$51.95M	$52.61M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$63.42M	$64.43M
YoY Change	-4.93%	-6.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.807B	$1.765B
YoY Change	7.74%	7.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$22.80M	$22.86M
YoY Change	0.13%	-2.41%
Total Long-Term Assets	$1.843B	$1.804B
YoY Change	7.43%	6.92%
TOTAL ASSETS
Total Short-Term Assets	$63.42M	$64.43M
Total Long-Term Assets	$1.843B	$1.804B
Total Assets	$1.907B	$1.868B
YoY Change	6.97%	6.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$51.31M	$52.69M
YoY Change	33.62%	46.57%
Accrued Expenses	$2.900M	$3.100M
YoY Change	-19.44%	-16.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$76.68M	$78.25M
YoY Change	19.0%	27.51%
LONG-TERM LIABILITIES
Long-Term Debt	$1.294B	$1.251B
YoY Change	11.06%	9.75%
Other Long-Term Liabilities	$21.84M	$22.97M
YoY Change	-4.02%	-3.76%
Total Long-Term Liabilities	$1.316B	$1.274B
YoY Change	10.77%	9.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$76.68M	$78.25M
Total Long-Term Liabilities	$1.316B	$1.274B
Total Liabilities	$1.393B	$1.352B
YoY Change	11.19%	10.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$280.9M	-$277.0M
YoY Change	6.61%	6.75%
Common Stock	$240.0K	$240.0K
YoY Change	0.0%	0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$395.4M	$396.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.907B	$1.868B
YoY Change	6.97%	6.41%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$13.16M	$13.50M
YoY Change	1.12%	1.03%
Depreciation, Depletion And Amortization	$12.11M	$12.02M
YoY Change	-2.12%	-2.51%
Cash From Operating Activities	$32.59M	$36.10M
YoY Change	23.12%	-9.78%
INVESTING ACTIVITIES
Capital Expenditures	$56.21M	$43.16M
YoY Change	-260.39%	-355.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$56.21M	-$43.16M
YoY Change	60.39%	155.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	23.28M	$5.591M
YoY Change	213.45%	-121.99%
NET CHANGE
Cash From Operating Activities	32.59M	$36.10M
Cash From Investing Activities	-56.21M	-$43.16M
Cash From Financing Activities	23.28M	$5.591M
Net Change In Cash	-339.0K	-$1.467M
YoY Change	-70.42%	-35.69%
FREE CASH FLOW
Cash From Operating Activities	$32.59M	$36.10M
Capital Expenditures	$56.21M	$43.16M
Free Cash Flow	-$23.62M	-$7.058M
YoY Change	-138.39%	-112.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000907254
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-12254
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SAUL CENTERS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-1833074
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	7501 Wisconsin Avenue
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Bethesda
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20814
CY2023Q1	dei	City Area Code CityAreaCode	301
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	986-6200
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11812000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13279000	usd
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23927240	shares
CY2023Q1	us-gaap	Land Land	511529000	usd
CY2022Q4	us-gaap	Land Land	511529000	usd
CY2023Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1583705000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1576924000	usd
CY2023Q1	us-gaap	Development In Process DevelopmentInProcess	365612000	usd
CY2022Q4	us-gaap	Development In Process DevelopmentInProcess	319683000	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2460846000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2408136000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	698597000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	688475000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1762249000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1719661000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	52614000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	56323000	usd
CY2023Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	22855000	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	22388000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	18475000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	21651000	usd
CY2023Q1	us-gaap	Assets Assets	1868005000	usd
CY2022Q4	us-gaap	Assets Assets	1833302000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	959395000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	961577000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	192134000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	161941000	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	99419000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	99382000	usd
CY2023Q1	bfs	Accounts Payable Accrued Expenses And Other Liabilities AccountsPayableAccruedExpensesAndOtherLiabilities	55790000	usd
CY2022Q4	bfs	Accounts Payable Accrued Expenses And Other Liabilities AccountsPayableAccruedExpensesAndOtherLiabilities	42978000	usd
CY2022Q1	bfs	Deferred Compensation Arrangementwith Individual Employer Contribution Percentage Deferred Compensation DeferredCompensationArrangementwithIndividualEmployerContributionPercentageDeferredCompensation	3
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	22970000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	23169000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	22462000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	22453000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1352170000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1311500000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24029935	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24029935	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24016009	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24016009	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	240000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	240000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	447134000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	446301000	usd
CY2023Q1	bfs	Partnership Units In Escrow PartnershipUnitsInEscrow	39650000	usd
CY2022Q4	bfs	Partnership Units In Escrow PartnershipUnitsInEscrow	39650000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-277020000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-273559000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1402000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2852000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	396406000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	400484000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	119429000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	121318000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	515835000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	521802000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1868005000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1833302000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	61829000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	60680000	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	1220000	usd
CY2022Q1	us-gaap	Other Operating Income OtherOperatingIncome	1464000	usd
CY2023Q1	us-gaap	Revenues Revenues	63049000	usd
CY2022Q1	us-gaap	Revenues Revenues	62144000	usd
CY2023Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8785000	usd
CY2022Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	9538000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	7495000	usd
CY2022Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	7418000	usd
CY2023Q1	bfs	Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees	11821000	usd
CY2022Q1	bfs	Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees	10602000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12017000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12327000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5268000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4768000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	45386000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	44653000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	17663000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	17491000	usd
CY2023Q1	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	4161000	usd
CY2022Q1	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	4126000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13502000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	13365000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2798000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2798000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10704000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	10704000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	10567000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10567000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2023Q1	us-gaap	Profit Loss ProfitLoss	17663000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	17491000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-2014000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	15649000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	17491000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3597000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4126000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12052000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13365000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2798000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2798000	usd
CY2023Q1	bfs	Total Comprehensive Income Loss Available To Common Stockholders TotalComprehensiveIncomeLossAvailableToCommonStockholders	9254000	usd
CY2022Q1	bfs	Total Comprehensive Income Loss Available To Common Stockholders TotalComprehensiveIncomeLossAvailableToCommonStockholders	10567000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	521802000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	13227	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	543000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	699	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	290000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	17663000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	19651000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	515835000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	530487000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	61861	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	2949000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	8007	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	594000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	17491000	usd
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	18917000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	530459000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	17663000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	17491000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12017000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12327000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	559000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	477000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	290000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	286000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-96000	usd
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	25000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-3805000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-2277000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	1519000	usd
CY2022Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	7900000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	496000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1083000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2519000	usd
CY2023Q1	bfs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	2495000	usd
CY2022Q1	bfs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	6386000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	199000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1321000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36098000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	39971000	usd
CY2023Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	5019000	usd
CY2022Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	2653000	usd
CY2023Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	38137000	usd
CY2022Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	14176000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43156000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16829000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	15300000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	17419000	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	36473000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	11000000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	8000000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	378000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3194000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	543000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3257000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Limited Partners Units ProceedsFromIssuanceOfCommonLimitedPartnersUnits	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Limited Partners Units ProceedsFromIssuanceOfCommonLimitedPartnersUnits	653000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	14171000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13583000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	5486000	usd
CY2022Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	5284000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5591000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25423000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1467000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2281000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13279000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14594000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11812000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12313000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	11002000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	9737000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	29323000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12135000	usd
CY2023Q1	bfs	Minimum Percentage Of Taxable Income Distribution To Shareholders MinimumPercentageOfTaxableIncomeDistributionToShareholders	0.90
CY2023Q1	bfs	Number Of Subsidiaries NumberOfSubsidiaries	2	subsidiary
CY2023Q1	us-gaap	Number Of Stores NumberOfStores	33	store
CY2023Q1	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	4200000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The most significant estimates and assumptions relate to collectability of operating lease receivables and impairment of real estate properties. Actual results could differ from those estimates.</span></div>
CY2023Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	9400000	usd
CY2023Q1	bfs	Accrued Rent Write Offs AccruedRentWriteOffs	300000	usd
CY2023Q1	bfs	Accrued Rent Amount Accrued Not Yet Due AccruedRentAmountAccruedNotYetDue	700000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the prior year financial statements to conform to the presentation used as of and for the three months ended March 31, 2023.</span></div>
CY2022Q1	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	4100000	usd
CY2023Q1	us-gaap	Development In Process DevelopmentInProcess	365612000	usd
CY2022Q4	us-gaap	Development In Process DevelopmentInProcess	319683000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3000000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3100000	usd
CY2023Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	22900000	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	22400000	usd
CY2023Q1	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	52100000	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	51300000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11000000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11200000	usd
CY2023Q1	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	3300000	usd
CY2022Q1	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	4500000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q1	us-gaap	Limited Partners Capital Account Units Outstanding LimitedPartnersCapitalAccountUnitsOutstanding	8800000	shares
CY2022Q3	bfs	Number Of Interest Rate Swaps NumberOfInterestRateSwaps	2	swap
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1270000000	usd
CY2023Q1	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	1070000000.00	usd
CY2023Q1	us-gaap	Longterm Debt Percentage Bearing Variable Interest Amount LongtermDebtPercentageBearingVariableInterestAmount	194000000	usd
CY2023Q1	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1040000000.00	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1240000000	usd
CY2022Q4	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	1070000000.00	usd
CY2022Q4	us-gaap	Longterm Debt Percentage Bearing Variable Interest Amount LongtermDebtPercentageBearingVariableInterestAmount	164000000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1040000000.00	usd
CY2023Q1	bfs	Longterm Debt Maturities Repayments Of Principal And Balloon Payments Remainder Of Fiscal Year LongtermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsRemainderOfFiscalYear	24931000	usd
CY2023Q1	bfs	Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year One LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearOne	83966000	usd
CY2023Q1	bfs	Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearTwo	246086000	usd
CY2023Q1	bfs	Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearThree	162468000	usd
CY2023Q1	bfs	Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearFour	123792000	usd
CY2023Q1	bfs	Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearFive	41863000	usd
CY2023Q1	bfs	Long Term Debt Maturities Repayments Of Principal And Balloon Payments After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsAfterYearFive	583457000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1266563000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15615000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1250948000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15600000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15800000	usd
CY2023Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	8300000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	15513000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	12313000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	559000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	477000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	4142000	usd
CY2022Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	2187000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	11930000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	10603000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	109000	usd
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	1000	usd
CY2023Q1	bfs	Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees	11821000	usd
CY2022Q1	bfs	Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees	10602000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24026000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23884000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	14000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24026000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23898000	shares
CY2023Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2023Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	111800	usd
CY2022Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	112200	usd
CY2023Q1	bfs	Deferred Compensation Arrangement With Individual Contributions By Plan Participants Percentage Of Salary Maximum DeferredCompensationArrangementWithIndividualContributionsByPlanParticipantsPercentageOfSalaryMaximum	0.02
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Contributions By Employer DeferredCompensationArrangementWithIndividualContributionsByEmployer	63000	usd
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Contributions By Employer DeferredCompensationArrangementWithIndividualContributionsByEmployer	46800	usd
CY2023Q1	bfs	Deferred Compensation Arrangementwith Individual Employer Contribution Percentage Deferred Compensation DeferredCompensationArrangementwithIndividualEmployerContributionPercentageDeferredCompensation	3
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	2900000	usd
CY2022Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	3000000	usd
CY2023Q1	bfs	Ancillary Costs And Expenses AncillaryCostsAndExpenses	2700000	usd
CY2022Q1	bfs	Ancillary Costs And Expenses AncillaryCostsAndExpenses	2400000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	900000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1200000	usd
CY2023Q1	bfs	Operating Leases Annual Increase In Rent Expense OperatingLeasesAnnualIncreaseInRentExpense	0.03
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	219400	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	192900	usd
CY2023Q1	us-gaap	Operating Insurance And Claims Costs Production OperatingInsuranceAndClaimsCostsProduction	222100	usd
CY2022Q1	us-gaap	Operating Insurance And Claims Costs Production OperatingInsuranceAndClaimsCostsProduction	70700	usd
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	2347	shares
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	116306	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	300000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1900000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1768375	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.28
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	bfs	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	24375	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	47.70
CY2023Q1	bfs	Sharebased Compensation Arrangementby Sharebased Payment Award Options Forfeituresand Expirationsin Period Intrinsic Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodIntrinsicValue	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1744000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.33
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1237250	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	52.76
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	43548	usd
CY2023Q1	us-gaap	Share Price SharePrice	39.00
CY2023Q1	bfs	Share Based Compensation Arrangement By Share Based Payment Award Options Grants Since Inception ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsSinceInception	1800000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M
CY2023Q1	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	935100000	usd
CY2022Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	919200000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	1070000000.00	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1070000000.00	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-396000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	us-gaap	Revenues Revenues	63049000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16280000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	46769000	usd
CY2023Q1	bfs	Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees	11821000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12017000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5268000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	17663000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	43156000	usd
CY2023Q1	us-gaap	Assets Assets	1868005000	usd
CY2022Q1	us-gaap	Revenues Revenues	62144000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16956000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	45188000	usd
CY2022Q1	bfs	Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees	10602000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12327000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4768000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	17491000	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	16829000	usd
CY2022Q1	us-gaap	Assets Assets	1755552000	usd

Files In Submission

Name	View Source	Status
bfs-20230331_pre.xml	Edgar Link	unprocessable
bfs-20230331_cal.xml	Edgar Link	unprocessable
0000907254-23-000039-index-headers.html	Edgar Link	pending
0000907254-23-000039-index.html	Edgar Link	pending
0000907254-23-000039.txt	Edgar Link	pending
0000907254-23-000039-xbrl.zip	Edgar Link	pending
bfs-03312023xex31.htm	Edgar Link	pending
bfs-03312023xex32.htm	Edgar Link	pending
bfs-03312023xex99a.htm	Edgar Link	pending
bfs-20230331.htm	Edgar Link	pending
bfs-20230331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
bfs-20230331_lab.xml	Edgar Link	unprocessable
bfs-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bfs-20230331_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BFS
SAUL CENTERS, INC. Stock $bfs

2023 Q2 Form 10-Q Financial Statement

#000090725423000039 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFS SAUL CENTERS, INC. Stock $bfs

2023 Q2 Form 10-Q Financial Statement

#000090725423000039 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFS
SAUL CENTERS, INC. Stock $bfs